David Kirske
Direttore Finanziario/CFO presso CTI BIOPHARMA CORP.
Profilo
David H.
Kirske is currently the CFO, Secretary & Executive Vice President at CTI BioPharma Corp.
He previously held positions as the Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., and Treasurer & Controller at F5, Inc. Mr. Kirske completed his undergraduate degree at the University of Puget Sound.
Posizioni attive di David Kirske
| Società | Posizione | Inizio |
|---|---|---|
| CTI BIOPHARMA CORP. | Direttore Finanziario/CFO | 26/09/2017 |
Precedenti posizioni note di David Kirske
| Società | Posizione | Fine |
|---|---|---|
| HELIX BIOMEDIX, INC. | Direttore Finanziario/CFO | 23/06/2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - |
| F5, INC. | Comptroller/Controller/Auditor | - |
Formazione di David Kirske
| University of Puget Sound | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Aziende private | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
- Borsa valori
- Insiders
- David Kirske
